CD79A and type 1 diabetes mellitus: TMSB15A was enriched in 18 items, with TOP 10 pathway as Graft Versus Host Disease, Autoimmune Thyroid Disease, Allograft Rejection, Type I Diabetes Mellitus, Intestinal Immune Network for IgA Production, Asthma, Primary Immunodeficiency, Cytosolic DNA Sensing Pathway, N Glycan Biosynthesis, Glycosaminoglycan Biosynthesis Chondroitin Sulfate (Figure 10d, Table 8, Table S25–26).